申请人:PAGANO Patrick J.
公开号:US20160083351A1
公开(公告)日:2016-03-24
Embodiments of bridged tetrahydroisoquinolines and methods for their use in selectively inhibiting nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 2 are disclosed. The disclosed compounds have a structure according to general formula I or a pharmaceutically acceptable salt thereof:
wherein “
” represents a single or double bond, R
1
is hydrogen, halogen, lower aliphatic, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; R
a
is hydrogen, —CH
2
R
2
, R
3
, or —SO
2
R
4
; R
2
is lower aliphatic, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; R
3
is substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl; R
4
is lower aliphatic, or substituted or unsubstituted aryl; and R
5
is hydrogen, halogen, or lower aliphatic.